Investopedia: Hologic Struggling To Find A New Path

Hologic 's (Nasdaq: HOLX ) difficult midlife crisis continues. With its core cervical cancer screening business struggling in response...

Investopedia: Becton Dickinson Already Priced For Excellence

It's pretty rare to see an “Underperform” rating on a med-tech stock these days, but Becton Dickinson (NYSE: BDX ) carries more than Jo...

Investopedia: Recent Financials May Not Be Entirely Fair To Hologic

I have no qualms with those who believe it is the responsibility of the management of public companies to communicate clearly and accuratel...